The Biopsy Devices Market size was estimated at USD 10.46 billion in 2024 and expected to reach USD 11.61 billion in 2025, at a CAGR 10.91% to reach USD 19.48 billion by 2030.

The biopsy devices market encompasses a variety of instrumentations used for diagnosing various diseases, notably cancers, by extracting and examining tissue samples from the body. These devices are indispensable in advancing medical diagnostics, offering precision in identifying disease presence and stage. Biopsy instruments find applications across numerous medical settings, including hospitals, diagnostic centers, and specialty clinics, with significant use in procedures such as needle biopsy, surgical biopsy, and endoscopic biopsy. The end-use scope extends to healthcare professionals specializing in oncology, gastroenterology, and urology, among others. Key growth factors influencing this market include the rising prevalence of cancer, technological advancements in imaging and minimally invasive procedures, and increasing demand for better diagnostic precision. The rapid adoption of advanced biopsy technologies, such as vacuum-assisted devices and 3D imaging augmented systems, presents lucrative opportunities. The integration of artificial intelligence to enhance diagnostic accuracy and efficiency further amplifies growth prospects. However, market expansion is hindered by challenges like high costs of advanced biopsy devices, stringent regulatory environments, and lack of trained professionals in emerging markets. Limitations also stem from potential risks associated with certain biopsy procedures that can deter their usage. Amidst these challenges, innovation should focus on cost-effective, pain-minimizing biopsy techniques and AI-enabled diagnostic tools to enhance procedural accuracy and outcome predictions. Potential research areas include the development of smart biopsy instruments that integrate real-time image analytics and improved sample collection techniques. The nature of the biopsy devices market is competitive and rapidly evolving, driven by technological advancements and increasing healthcare demands. To capitalize on market potential, stakeholders need to invest in R&D, focus on strategic partnerships, and emphasize training programs to offset professional shortages, thereby ensuring market growth and improved patient outcomes.
Ask ResearchAI anything
World's First Innovative Al for Market Research
Market Dynamics
The market dynamics represent an ever-changing landscape of the Biopsy Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
- Market Drivers
- Healthcare industry shift towards precision medicine influencing advanced diagnostic modalities
- Increasing prevalence of cancer leading to higher demand for early and precise diagnostic tools
- Developments in minimally invasive biopsy procedures improving patient comfort and recovery time
- Market Restraints
- Challenges in reimbursement policies affecting the market penetration of biopsy devices
- Key constraints influencing the commercial viability of the global biopsy device industry
- Navigating ethical and privacy issues in biopsy procedures within different regulatory environments
- Market Opportunities
- Technological improvements in wireless connectivity provide new avenues for smart biopsy devices
- Growing demand for minimally invasive diagnostic procedures elevates the importance of biopsy devices
- Integration of AI and machine learning in biopsy devices is set to revolutionize diagnostic accuracy
- Market Challenges
- Navigating stringent regulatory approvals and compliance in the biopsy devices market
- Managing competitive pressures from established and emerging players in the biopsy industry
- Mitigating the risk of cybersecurity threats in digital biopsy devices and connected systems
Market Segmentation Analysis
Product: Growing preference for needle-based biopsy instruments as it provide minimal risk of complications
Biopsy forceps are sophisticated, hand-held devices used during minimally invasive procedures, designed with a two-leaf structure; they are adept at extracting tissue samples from targeted areas with sheer precision and minimal patient discomfort. Localization wires act as a guide in identifying the correct area for biopsy, particularly in breast biopsy procedures. They are used preoperatively to seperate non-palpable lesions detected during mammography or ultrasound, ensuring precision and aiding radiologists in obtaining tissue samples. Needle-based biopsy instruments are preferred for deep-seated lesions; common types include fine-needle aspiration and core-needle biopsies. These devices reduce procedural complications and are known for their efficiency in obtaining high-quality samples, helping in precise diagnoses. Needle-based biopsy instruments include aspiration needles, core biopsy devices, and vacuum-assisted biopsy devices. Aspiration needles play a crucial role in fine-needle aspiration biopsy procedures, often used to investigate lumps or masses. Core biopsy devices remove a small tissue section for pathological examination, usually used in breast, liver, or bone biopsies. Vacuum-assisted biopsy devices are remarkably efficient tools for minimally invasive biopsy procedures. Employing a vacuum mechanism, these devices allow for a continuous tissue sample to be acquired without reinserting the needle. Procedure trays are a compact, systematic solution encompassing all necessary biopsy tools for a specific procedure. They optimize the workflow, promote efficient resource use, and enhance the sterility of the procedure.
Technique: Significant role of MRI-guided biopsy in biopsy device for high diagnosis accuracy
Image-guided biopsy is a noteworthy innovation in the realm of biopsy devices, harnessing the precision of modern imaging technologies. This advanced technique enables doctors to extract samples from difficult-to-access areas, leading to a more accurate and less invasive procedure. Image-guided biopsy includes MRI-guided biopsy, stereotactic-guided biopsies, and ultrasound-guided biopsy. MRI-guided biopsy has become a preferred technique for diagnosing abnormalities located in difficult-to-reach areas or those of more intricate structures such as the brain and the breast. Stereotactic-guided biopsies are more applicable for relatively superficial abnormalities, including those in the breast and lesions close to the skin. This technique is a boon for patients to avoid the discomfort of invasive procedures while still ensuring a highly accurate diagnosis. Ultrasound-guided biopsy primarily leverages its advantage in real-time image provision, making it the go-to option for neck, chest, and abdomen biopsies. Furthermore, it is a cost-effective and faster way of performing biopsies and is preferred in situations where cost and time are primary considerations. In comparison, MRI-guided biopsy stands at the forefront of advanced cases, stereotactic biopsy rings are necessary for superficial cases, and ultrasound-guided offerings are proven beneficial in real-time requirements and cost-effective scenarios. Non-image guided biopsy includes techniques where palpation or anatomical landmarks are used to determine the biopsy site without the assistance of live-image guidance. The choice between image-guided and non-image-guided biopsies largely depends on the location and nature of the lesion, the patient’s health status, and the resources available. Image-guided biopsy methods are leading in the context of precision and safety, particularly for non-palpable and deep-seated lesions. However, non-image-guided procedures remain a fast and cost-effective option for superficial masses.
Porter’s Five Forces Analysis
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Biopsy Devices Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
PESTLE Analysis
The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Biopsy Devices Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biopsy Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biopsy Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Recent Developments
LUMINELLE Announces China National Intellectual Property Administration’s Decision to Grant Issuance of Patent for LUMINELLE Bx (Biopsy) System, Expanding Global Footprint
LUMINELLE (UVision360, Inc.) has been granted a Chinese patent titled "Biopsy Device and Method" for its Bx System, securing international intellectual property rights. This groundbreaking system reduces the need for anesthesia, allowing for accurate sampling in the office setting. [Published On: October 05, 2023]
Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI Endoscopic Biopsy Device
Limaca Medical Ltd.'s Precision GI Endoscopic Ultrasound (EUS) Biopsy Device has received 510(k) clearance from the FDA after being designated as a Breakthrough Device. This device is designed to enhance the accuracy and efficiency of biopsies, enabling a more definitive diagnosis of pancreatic and other gastrointestinal (GI) cancers. [Published On: September 11, 2023]
Stryker Announces Commercial Launch of Q Guidance System with Cranial Guidance Software
Stryker Corporation launched the Q Guidance System with Cranial Guidance Software. This innovative system is designed to assist surgeons in accurately positioning instruments and identifying patient anatomy during cranial surgery. It is particularly beneficial for craniotomies, skull base and transsphenoidal procedures, shunt placements, and biopsies. [Published On: July 11, 2023]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biopsy Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Axlab Limited, B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., CONMED Corporation, Cook Group Incorporated, Danaher Corporation, F. Hoffmann-La Roche Ltd., Ferrosan Medical Devices A/S, Fujifilm Holdings Corporation, Guardant Health, Inc., Hologic, Inc., Innovia Medical, INRAD, Inc., Integra LifeSciences Holdings Corporation, IZI Medical Products, LLC by Halma PLC, JEB Technologies Limited, Limaca-Medical, MediTech Devices Pvt Ltd., Medtronic PLC, Merit Medical Systems, Inc., Mermaid Medical, Olympus Corporation, PAJUNK GmbH Medizintechnologie, Remington Medical, Spectra Medical Devices, LLC, Stryker Corporation, Suretech Medical Inc., Trajan Scientific and Medical Pty Ltd., TransMed7, LLC, TSK Laboratory, UVision360, Volkmann MedizinTechnik GmbH, weLLgo Medical Products GmbH, and Zamar Care.
Market Segmentation & Coverage
This research report categorizes the Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Brush Biopsy Devices
- Forceps Biopsy Devices
- Needle Biopsy Devices
- Procedure Type
- Closed Biopsy
- Open Biopsy
- Excisional Biopsy
- Incisional Biopsy
- Application
- Bone Marrow Biopsy
- Breast Biopsy
- Colorectal Biopsy
- Liver Biopsy
- Lung Biopsy
- Prostate Biopsy
- End User
- Diagnostic Centers
- Hospitals
- Specialty Clinics
- Product Type
- Biopsy Forceps
- Biopsy Guns
- Core Biopsy Devices
- Needle Aspiration Biopsy Devices
- Guidance Technique
- MRI-Guided Biopsy
- Stereotactic-Guided Biopsy
- Ultrasound-Guided Biopsy
- Core Needle
- Technology
- Fine Needle Aspiration Biopsy
- Vacuum-Assisted Biopsy
- Laser Type
- Gas Laser
- Solid-State Laser
- Biomaterial Involved
- Metallic Biomaterials
- Polymeric Biomaterials
- Automation Level
- Fully Automatic Biopsy Devices
- Manual Biopsy Devices
- Semi-Automatic Biopsy Devices
- Design
- Disposable Biopsy Devices
- Reusable Biopsy Devices
- Patient Type
- Adult
- Pediatric
- Tissue Sample Size
- Large Tissue Biopsy
- Small Tissue Biopsy
- Safety Features
- Non-Safety Devices
- Safety-Engineered Devices
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
This research report offers invaluable insights into various crucial aspects of the Biopsy Devices Market:
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Biopsy Devices Market, by Type
- Biopsy Devices Market, by Procedure Type
- Biopsy Devices Market, by Application
- Biopsy Devices Market, by End User
- Biopsy Devices Market, by Product Type
- Biopsy Devices Market, by Guidance Technique
- Biopsy Devices Market, by Technology
- Biopsy Devices Market, by Laser Type
- Biopsy Devices Market, by Biomaterial Involved
- Biopsy Devices Market, by Automation Level
- Biopsy Devices Market, by Design
- Biopsy Devices Market, by Patient Type
- Biopsy Devices Market, by Tissue Sample Size
- Biopsy Devices Market, by Safety Features
- Americas Biopsy Devices Market
- Asia-Pacific Biopsy Devices Market
- Europe, Middle East & Africa Biopsy Devices Market
- Competitive Landscape
- List of Figures [Total: 45]
- List of Tables [Total: 725 ]
- List of Companies Mentioned [Total: 38]

- How big is the Biopsy Devices Market?
- What is the Biopsy Devices Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?